Study guide

9.5 Hypersensitivity Reactions in Dental Practice

Overseas Registration Examination ORE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: ORE Part 1 — Exam Blueprint, Logistics and Strategy

1.1 Structure and Format of ORE Part 1 1.2 The Official Blueprint and Preparing for Practice 1.3 Eligibility, Fees, Attempts and Time Limits

2 Chapter 2: Anatomy of the Head and Neck

2.1 The Trigeminal Nerve and Dental Innervation 2.2 The Facial Nerve and Parotid Region 2.3 The Temporomandibular Joint and Muscles of Mastication 2.4 The Infratemporal Fossa and Spread of Odontogenic Infection

3 Chapter 3: Dental Anatomy, Morphology and Occlusion

3.1 Permanent and Primary Tooth Morphology 3.2 Functional Occlusion: Centric Relation, Guidance and Interferences 3.3 Classifying Occlusion: Angle and BSI Incisor Relationships

4 Chapter 4: Genetics, Embryology and Odontogenesis

4.1 Stages of Odontogenesis and Molecular Signalling 4.2 Amelogenesis and Enamel Microstructure 4.3 Dentinogenesis and the Pulp-Dentine Complex 4.4 Cementum, the Periodontal Ligament and Oral Mucosa 4.5 Genetic and Developmental Dental Anomalies

5 Chapter 5: Oral Biology and Salivary Physiology

5.1 Salivary Gland Anatomy, Microarchitecture and Innervation 5.2 Salivary Secretion, Flow Rates and Autonomic Control 5.3 Salivary Buffering Systems and Protective Macromolecules 5.4 Physiology of Mastication and Deglutition 5.5 Taste, Lingual Papillae and Gustatory Pathways 5.6 Xerostomia, Sjogren's Syndrome and Salivary Diagnostics

6 Chapter 6: Physiology of the Major Body Systems

6.1 Cardiovascular and Respiratory Physiology 6.2 Renal, Endocrine and Gastrointestinal Physiology 6.3 Haematology and Haemostasis 6.4 Neurophysiology, Pain and the Autonomic Nervous System

7 Chapter 7: Bone Biology, Calcium Homeostasis and Healing

7.1 Microstructure and Architecture of Alveolar Bone 7.2 Bone Remodelling and the RANK/RANKL/OPG Axis 7.3 Endocrine Control of Calcium and Phosphate 7.4 Extraction Socket Healing and Ridge Resorption 7.5 Impaired Healing: MRONJ, Osteoradionecrosis and Systemic Risk

8 Chapter 8: Oral Microbiology and Biofilm Ecology

8.1 The Oral Microbiome and Biofilm Development 8.2 Cariogenic Microbiology: Mutans Streptococci and Lactobacilli 8.3 Ecological Hypotheses of Dental Caries 8.4 Biofilm Tolerance and the Case for Mechanical Plaque Control

9 Chapter 9: Immunology Relevant to Oral Disease

9.1 Innate Mucosal Immunity and Gingival Crevicular Fluid 9.2 Cellular Immunity in the Periodontium 9.3 Microbial Pathogenesis: Complexes and Keystone Pathogens 9.4 Host-Mediated Tissue Destruction 9.5 Hypersensitivity Reactions in Dental Practice 9.6 Autoimmune Mucocutaneous Bullous Disease 9.7 Immunodeficiency and Oral HIV Manifestations

10 Chapter 10: General Pathology and Neoplasia

10.1 Cellular Adaptation and Mechanisms of Cell Death 10.2 Inflammation, Wound Healing and Repair 10.3 Principles of Neoplasia and Carcinogenesis 10.4 TNM Staging of Oral Cavity Carcinoma

11 Chapter 11: Statistics and Research Methods

11.1 Study Designs and the Hierarchy of Evidence 11.2 Descriptive and Inferential Statistics 11.3 Diagnostic Test Performance 11.4 Critical Appraisal, Bias and Research Governance

12 Chapter 12: Human Disease: Cardiovascular and Respiratory

12.1 Infective Endocarditis and NICE CG64 12.2 Hypertension and Blood Pressure Thresholds for Dental Care 12.3 Angina, Myocardial Infarction and Antiplatelet Therapy 12.4 Asthma, COPD and Respiratory Emergencies

13 Chapter 13: Human Disease: Endocrine, Haematological and Renal

13.1 Diabetes Mellitus and the Periodontal Axis 13.2 Congenital Bleeding and Clotting Disorders 13.3 Anticoagulants and Antiplatelets: The SDCEP Protocol 13.4 Chronic Kidney Disease and Haemodialysis

14 Chapter 14: Human Disease: Gastrointestinal, Hepatic and Neurological

14.1 Gastrointestinal Disease and Intrinsic Dental Erosion 14.2 Liver Disease, Coagulopathy and Viral Hepatitis 14.3 Epilepsy, Stroke and Transient Ischaemic Attack 14.4 Trigeminal Neuralgia, Bell's Palsy and Giant Cell Arteritis

15 Chapter 15: Oral Aspects of Human Disease

15.1 Oral Manifestations of Systemic Disease 15.2 Orofacial Pain and Temporomandibular Disorders 15.3 Dry Mouth, Altered Taste and Halitosis

16 Chapter 16: Infection Prevention and Control

16.1 The Decontamination Cycle, Sterilization and Waterlines 16.2 Routes of Transmission and Blood-Borne Viruses

17 Chapter 17: Dental Materials

17.1 Dental Amalgam: Metallurgy and UK Regulation 17.2 Resin Composites: Chemistry and Placement 17.3 Dental Adhesive Systems 17.4 Acid Etching, the Hybrid Layer and MMP Degradation 17.5 Glass Ionomer Cements, RMGICs and Compomers 17.6 Impression Materials and Digital Scanning 17.7 Luting Cements and Adhesive Conditioning Protocols 17.8 Dental Ceramics and Cast Alloys 17.9 Gypsum Products, Waxes and Denture Base Polymers

18 Chapter 18: Behavioural Sciences Relevant to Oral Health Care

18.1 Health Behaviour Models and Behaviour Change 18.2 Dental Anxiety and Phobia 18.3 Psychosocial and Sociological Determinants of Oral Health

19 Chapter 19: Patient Assessment and Diagnosis

19.1 History Taking and Clinical Examination 19.2 Special Investigations and Reaching a Diagnosis

20 Chapter 20: Treatment Planning and Risk-Based Care

20.1 Treatment Planning and Sequencing 20.2 Risk Assessment, Recall Intervals and Preventive Planning

21 Chapter 21: Cariology and Caries Risk Assessment

21.1 Caries Pathogenesis and the Stephan Curve 21.2 Histopathology of Enamel and Dentinal Caries 21.3 Caries Diagnosis, ICDAS and Risk Assessment

22 Chapter 22: Operative Dentistry and Minimal Intervention

22.1 Minimal Intervention and Selective Caries Removal 22.2 Pulp Vitality Assessment and Biological Pulp Capping 22.3 Cavity Design, the C-Factor and Margin Geometry

23 Chapter 23: Endodontics

23.1 Pulp Histology and the Low-Compliance Environment 23.2 Pulpal Neurophysiology and Dentine Hypersensitivity 23.3 Pulpal and Periapical Diagnostic Terminology 23.4 Endodontic Diagnostic Testing 23.5 Access Cavity Design and Canal Configurations 23.6 Working Length Determination and Canal Preparation 23.7 Chemical Disinfection and Irrigant Activation 23.8 Medicaments, Obturation Materials and Techniques 23.9 Restoring Endodontically Treated Teeth 23.10 Endodontic Emergencies, Cracked Teeth and Root Fracture

24 Chapter 24: Periodontology

24.1 The 2018 Classification and Periodontal Health 24.2 Plaque-Induced and Non-Plaque-Induced Gingival Disease 24.3 Staging and Grading Periodontitis 24.4 Peri-Implant Disease and Systemic Risk Factors 24.5 The Basic Periodontal Examination 24.6 Simplified BPE in Children and Full Periodontal Charting 24.7 Furcation Involvement, Mobility and Occlusal Trauma 24.8 The BSP Stepwise Treatment Framework 24.9 Periodontal Instrumentation and Healing 24.10 Re-Evaluation, Endpoints and Periodontal Surgery 24.11 Crown Lengthening, Supracrestal Attachment and Supportive Care

25 Chapter 25: Fixed Prosthodontics

25.1 Biomechanical Principles of Tooth Preparation 25.2 Margin Design and the Supracrestal Attachment 25.3 Bridge Design and Resin-Bonded Bridges 25.4 Gingival Retraction, Provisionals and Temporary Cements

26 Chapter 26: Removable Prosthodontics

26.1 Removable Partial Dentures: Classification, Design and Surveying 26.2 Complete Dentures: Principles, Impressions and Jaw Registration

27 Chapter 27: Paediatric Dentistry

27.1 Primary Tooth Anatomy and Caries Management Strategies 27.2 Preformed Metal Crowns and the Hall Technique 27.3 Pulp Therapy in Primary Teeth 27.4 Extractions in the Primary Dentition 27.5 Non-Pharmacological Behaviour Management 27.6 Inhalation Sedation in Paediatric Dentistry 27.7 The Developing Dentition and Space Management 27.8 Serial Extraction and Non-Nutritive Sucking Habits

28 Chapter 28: Dental Traumatology

28.1 Trauma Assessment and Fractures of Permanent Teeth 28.2 Luxation Injuries, Avulsion and Replantation 28.3 Primary Tooth Trauma and Splinting Specifications

29 Chapter 29: Orthodontics

29.1 Extraoral Orthodontic Assessment 29.2 Intraoral Occlusal Assessment 29.3 Skeletal Pattern and Cephalometric Analysis 29.4 IOTN and NHS Treatment Eligibility 29.5 Upper Removable Appliances 29.6 Functional and Fixed Appliances 29.7 Biology of Orthodontic Tooth Movement 29.8 Orthodontic Risks and Retention

30 Chapter 30: Oral Surgery

30.1 Exodontia Biomechanics and Instrument Selection 30.2 Surgical Flap Design, Bone Removal and Suturing 30.3 Third Molar Surgery and NICE Guidance 30.4 Dry Socket and Oroantral Communication 30.5 Odontogenic Infection and Fascial Space Spread

31 Chapter 31: Oral Medicine

31.1 Recurrent Aphthous Stomatitis 31.2 Oral Candidiasis 31.3 Viral Oral Infections 31.4 Reactive Soft Tissue Lesions and the Epulides 31.5 Oral Potentially Malignant Disorders 31.6 Oral Squamous Cell Carcinoma, Urgent Referral and Biopsy

32 Chapter 32: Oral Pathology

32.1 Odontogenic and Non-Odontogenic Cysts 32.2 Odontogenic Tumours 32.3 Obstructive and Reactive Salivary Gland Disease 32.4 Salivary Gland Neoplasms

33 Chapter 33: Therapeutics and Prescribing

33.1 Local Anaesthetic Chemistry and Mechanism of Action 33.2 UK Local Anaesthetic Formulations 33.3 Vasoconstrictors, Maximum Doses and Systemic Toxicity 33.4 Analgesics for Acute Dental Pain 33.5 Antimicrobial Stewardship and First-Line Regimens 33.6 Antifungal and Antiviral Therapeutics

34 Chapter 34: Medical Emergencies in Dental Practice

34.1 The ABCDE Approach and the Emergency Drug Kit 34.2 Anaphylaxis and Acute Coronary Syndrome 34.3 Hypoglycaemia, Acute Asthma and Seizures 34.4 Syncope, Adrenal Crisis, Choking and Resuscitation

35 Chapter 35: Dental Radiology and Radiation Protection

35.1 Radiation Physics, Filtration and Collimation 35.2 Intraoral, Bitewing and Occlusal Projections 35.3 Dental Panoramic Tomography: Principles, Positioning and Errors 35.4 Lateral Cephalometry and Cone Beam CT 35.5 Systematic Reporting and Radiographic Caries Diagnosis 35.6 Radiology of Periodontal Bone Loss and Jaw Lesions 35.7 Radiographic Quality Assurance 35.8 IRR17 and IR(ME)R 2017

36 Chapter 36: Special Care Dentistry and Conscious Sedation

36.1 Special Care Dentistry, Risk Stratification and Sedation Principles 36.2 Inhalation Sedation with Nitrous Oxide 36.3 Intravenous Sedation with Midazolam 36.4 Oral Sedation and General Anaesthesia Referral

37 Chapter 37: Dental Public Health

37.1 Delivering Better Oral Health and the Fluoride Toolkit 37.2 Oral Health Epidemiology and Indices 37.3 Inequalities, Water Fluoridation and Population Prevention 37.4 NHS Dental Services, Access and Commissioning

38 Chapter 38: Communication and Interpersonal Skills

38.1 Patient Communication and Shared Decision-Making 38.2 Breaking Bad News, Complaints and the Duty of Candour 38.3 Referrals, Records and Communication with the Team

39 Chapter 39: Consent and Capacity

39.1 Valid Consent and the Montgomery Standard 39.2 The Mental Capacity Act 2005 39.3 Best Interests Decisions and Lasting Power of Attorney 39.4 Consent in Children and Young People 39.5 Safeguarding Children and Vulnerable Adults 39.6 Confidentiality, Data Protection and Lawful Disclosure

40 Chapter 40: Clinical Professionalism and the GDC

40.1 The General Dental Council and Standards Principles 1 to 4 40.2 GDC Standards: Principles 5 to 9 40.3 The GDC Fitness to Practise Process 40.4 Clinical Governance and the Audit Cycle

41 Chapter 41: Health and Safety Law in Dental Practice

41.1 Health and Safety Legislation, COSHH, RIDDOR and Sharps

42 Chapter 42: Self-Management and Professional Development

42.1 Enhanced CPD, Lifelong Learning and Reflective Practice 42.2 Managing Time, Stress and Clinical Wellbeing 42.3 Leadership, Delegation and Practice Management

9.5 Hypersensitivity Reactions in Dental Practice

Key Takeaways Explain This Topic AI

Type I reactions are IgE-mediated and immediate; type IV reactions are T-cell mediated and delayed for 24 to 72 hours.

Pemphigus vulgaris and mucous membrane pemphigoid are type II reactions, while systemic lupus erythematosus is type III.

Adrenaline for anaphylaxis is given intramuscularly into the anterolateral thigh as 1:1000 solution.

UK adrenaline doses are 500 micrograms for adults and children over 12, 300 micrograms for children 6 to 12, and 150 micrograms for children 6 months to 6 years.

Patients in anaphylaxis should be laid flat with legs raised; sitting them up risks empty ventricle cardiac arrest.

Last updated: September 2026

1. Coombs and Gell Classification of Hypersensitivity in Dental Practice

Robin Coombs and Philip Gell (1963) established the definitive immunological framework categorising hypersensitivity into four distinct mechanistic classes:

Type Mechanism Primary Immune Reactant Pathological Mediators Time to Onset Representative Dental / Clinical Examples

Type I (Immediate) IgE cross-linking on mast cells & basophils IgE Histamine, tryptase, leukotrienes (LTC₄, LTD₄), PGD2 Seconds to minutes (<30 mins) Anaphylaxis, penicillin allergy, natural rubber latex allergy, urticaria.

Type II (Cytotoxic) Antibody binding to fixed cell-surface / tissue antigens IgG , IgM Complement (MAC), phagocytosis via Fc/C3b, ADCC (NK cells) Hours to 24 hours Pemphigus vulgaris , Mucous membrane pemphigoid , autoimmune haemolytic anaemia.

Type III (Immune Complex) Soluble antigen-antibody complex deposition IgG , IgM (Immune complexes) Complement split products (C3a, C5a), neutrophil recruitment, vasculitis 4 to 10 hours Systemic lupus erythematosus (SLE) , serum sickness, reactive arthritis.

Type IV (Cell-Mediated) Sensitised T-cell activation & macrophage recruitment T lymphocytes (CD4+ Th1, Th17; CD8+) IFN-γ, TNF-α, perforin, granzymes, macrophage activation 24 to 72 hours (Delayed) Contact stomatitis (nickel, methacrylate monomer), amalgam lichenoid reactions , Mantoux test.

Type I: Immediate Hypersensitivity & Dental Anaphylaxis

Type I hypersensitivity occurs in two distinct phases:

Sensitisation Phase: An environmental allergen (e.g., penicilloyl-protein conjugate from amoxicillin, or hevein proteins from latex) is sampled by dendritic cells, which present it to naive CD4+ T cells. Driven by IL-4 and IL-13, these differentiate into Th2 cells , which stimulate B cells to undergo immunoglobulin class-switching to IgE . Synthesised IgE binds via its constant region with picomolar affinity to high-affinity receptors ( FcεRI ) on tissue mast cells and circulating basophils, rendering the host "sensitised".

Challenge (Effector) Phase: Upon re-exposure, the bivalent or multivalent allergen cross-links adjacent FcεRI-bound IgE molecules on the mast cell membrane. This cross-linking activates Lyn and Syk tyrosine kinases, mobilising intracellular calcium (Ca²⁺) and triggering:

Immediate release (within minutes): Pre-formed granular mediators, predominantly histamine (acting via H1 receptors to cause smooth muscle bronchoconstriction, arteriolar vasodilation, and increased venular permeability) and tryptase (a clinical biomarker for mast cell degranulation).

De novo lipid mediator synthesis (within 10–30 mins): Cleavage of arachidonic acid yielding Leukotrienes LTC₄, LTD₄, LTE₄ (which induce intense, prolonged bronchoconstriction and microvascular leakage 1,000-fold more potent than histamine) and Prostaglandin PGD2 .

Late-phase reaction (4–8 hours): Secretion of cytokines (IL-4, IL-5, TNF-α) driving tissue eosinophil and neutrophil infiltration.

UK Resuscitation Council Anaphylaxis Protocol in Dental Practice

Acute anaphylaxis is a medical emergency characterised by rapid-onset, life-threatening compromised Airway (pharyngeal/laryngeal oedema, hoarseness, stridor), Breathing (bronchospasm, wheezing, tachypnoea), and/or Circulation (profound hypotension, tachycardia, collapse), frequently accompanied by cutaneous manifestations (pruritus, urticaria, angioedema). [Recognise Acute Anaphylaxis: Airway / Breathing / Circulation Compromise]

  • │
  • ▼
  • [1. Stop administration of suspected allergen immediately]
  • [2. Call 999 for emergency medical assistance (state 'Anaphylaxis')]
  • [3. Position patient flat with legs elevated (unless breathing is impaired; NEVER stand)]
  • │
  • ▼
  • [4. Administer INTRAMUSCULAR (IM) ADRENALINE (1:1000, 1 mg/mL) into mid-outer thigh]
  • Adult / Child >12 years: 500 micrograms (0.5 mL)
  • Child 6–12 years: 300 micrograms (0.3 mL)
  • Child <6 years: 150 micrograms (0.15 mL)
  • │
  • ▼
  • [5. High-flow Oxygen (15 L/min via non-rebreather reservoir mask)]
  • [6. Repeat IM Adrenaline after 5 minutes if no clinical improvement]
  • [7. Secondary non-emergency adjuvants (Chlorphenamine, Hydrocortisone) once stabilized]

Caution

Critical Clinical Pearls — UK Anaphylaxis Management:

Route of Choice: Adrenaline must be administered intramuscularly (IM) into the anterolateral aspect of the middle third of the thigh (vastus lateralis) . The vastus lateralis has superior vascularity compared to the deltoid, ensuring rapid, reliable peak plasma concentrations within minutes. Subcutaneous injection is too slow; intravenous adrenaline is strictly reserved for specialist intensive care / anaesthetic teams due to lethal cardiac arrhythmia risks.

Patient Posture: Never allow an anaphylactic patient to stand or sit up suddenly. Sudden upright positioning causes catastrophic venous pooling in the lower extremities, leading to empty-ventricle pulseless electrical activity (PEA) and death ("empty heart syndrome").

Type IV: Delayed-Type Hypersensitivity in Dentistry

Unlike Types I–III, Type IV reactions are entirely cell-mediated and independent of antibodies:

Pathomechanism: Small lipophilic chemicals (<1,000 Da) known as haptens are not immunogenic on their own. Upon contacting oral mucosa, they penetrate the epithelial barrier and covalently conjugate with endogenous host tissue proteins. Intraepithelial Langerhans cells (CD1a+) internalise these haptenated neoantigens, migrate to regional lymph nodes, and prime antigen-specific CD4+ Th1 and CD8+ cytotoxic T cells .

Upon subsequent re-challenge, memory T cells infiltrate the mucosa and release pro-inflammatory cytokines, notably Interferon-gamma (IFN-γ) and TNF-α . IFN-γ activates tissue macrophages, resulting in localized release of reactive oxygen species, lysosomal proteases, basal cell liquefactive degeneration, and epithelial vesiculation over 24 to 72 hours .

Common Dental Culprits:

Residual Methylmethacrylate Monomer: Inadequately cured polymethylmethacrylate (PMMA) acrylic dentures release unpolymerised free monomer, causing intense contact stomatitis characterised by fiery red erythema strictly demarcated beneath the denture-bearing area.

Nickel, Cobalt, and Chromium: Released from base-metal orthodontic archwires and partial denture cobalt-chromium frameworks. Nickel is the single most common contact allergen in the UK population.

Eugenol: Found in zinc oxide-eugenol temporary dressings and impression pastes, causing contact cheilitis or localized mucosal ulceration.

Cinnamic Aldehyde (Cinnamon) & Flavourings: Additives in toothpastes and confectionery; contact cinnamon stomatitis presents with deep mucosal erythema, shaggy white keratosis, and ulceration resembling plasma cell gingivitis.

Oral Lichenoid Contact Lesions (OLCL): Type IV cell-mediated delayed hypersensitivity to corrosion products (mercury, copper) leaching from dental amalgam restorations. Lesions present with reticular white striae and erythema strictly confined to oral mucosal sites in direct physical contact with the offending amalgam restoration, resolving completely following replacement with composite resin or glass ionomer.

Diagnostic Investigation: The definitive diagnostic gold standard is Cutaneous Patch Testing (read at 48 hours and 72–96 hours). Skin prick testing evaluates immediate Type I IgE responses and is useless for Type IV delayed stomatitis.

The clinically important point is that the type of reaction determines both the time course and the emergency response. A type I reaction develops within minutes and may require adrenaline; a type IV reaction develops over one to three days and does not. This is why a patient who reports that a rash appeared two days after starting amoxicillin has a delayed reaction, which is unpleasant but not immediately dangerous, whereas one who reports facial swelling and wheeze within minutes has an immediate reaction and must never receive a penicillin again. Taking a history that establishes the timing, the symptoms and the outcome is therefore more useful than recording the single word "allergy".